Don't miss out on these discounted products!
Act fast before the sale ends!
The following products are currently out of stock
Don't miss out on these discounted products!
Act fast before the sale ends!
The following products are currently out of stock
This section outlines the evolution and milestones of Behemothlabz from its founding in 2014 to its continued growth and innovation in 2024.
This section provides all our contact details, encouraging you to reach out for assistance or inquiries. It encompasses live chat, phone support, and email options, ensuring accessibility for all.
Discover all you need to know to partner with us and promote our products to earn rewards.
In our FAQs section, we have compiled answers to the questions we frequently receive. Quickly find information about our company, products, and policies. If you have any questions, you might find the answer here before reaching out to us directly.
In our Quality Control and Testing section, we uphold Behemothlabz’s Commitment to Quality by meticulously detailing our procedures.
Sign up Here for our regular newsletter and stay updated.
$99.48
Earn 99 points upon purchasing this product.
LL-37, also known as CAP-18, is a fascinating peptide that is important for research on the innate immune system. This antimicrobial peptide belongs to the cathelicidin family and has a wide range of potential actions in the human body. While LL-37 has received attention for its potential medicinal applications, it is important to note that the information provided here is only for educational reasons and does not advocate or recommend any type of human intake.
Peptide LL-37 is produced from the C-terminus of the human cathelicidin antimicrobial protein (CAP-18). Cathelicidins are a class of peptides with antibacterial and immunomodulatory activities. The capacity of LL-37 to resist a wide spectrum of pathogens, including bacteria, viruses, and fungi, has piqued the curiosity of researchers. [R]
The chemical structure of LL-37 is made up of a series of 37 amino acids. In different conditions, the peptide takes on multiple conformations, allowing it to engage with distinct pathogens and modify immune responses efficiently. [R]
LL-37 exhibits robust antibacterial activity against a diverse range of pathogens, including bacteria, viruses, and fungi. It is a good option for the synthesis of novel antibacterial agents due to its capacity to damage microbial membranes. [R]
Peptides are essential for immune system modulation. It has the potential to balance the pro- and anti-inflammatory responses and increase the activity of immune cells, including dendritic cells and macrophages. This immunomodulatory role raises the possibility of using it in situations where immunological dysregulation is present. [R]
LL-37 may contribute to the wound-healing process by promoting cell migration, proliferation, and angiogenesis. Its ability to accelerate tissue repair suggests potential applications in wound care and regenerative medicine. [R]
LL-37 has been shown to possess anti-inflammatory properties by inhibiting the production of pro-inflammatory cytokines. This anti-inflammatory effect may have implications for conditions characterized by excessive inflammation, such as certain autoimmune diseases. [R]
LL-37, a human cathelicidin, exhibits potent antiviral activity against Respiratory Syncytial Virus (RSV) in vitro. It prevents virus-induced cell death, inhibits infectious particle production, and limits infection spread, offering a promising target for innate defense against RSV. Modulating LL-37 expression or using synthetic analogues may represent novel strategies for combating RSV infection. [R]
LL-37 (CAP-18) engages in a multifaceted role within the immune defense mechanisms. Firstly, it demonstrates direct antimicrobial activity by disrupting microbial membranes, enabling penetration of bacterial cell walls, and causing pathogen destabilization and death. [R]
Additionally, LL-37 serves a crucial function in immunomodulation, influencing the behavior of immune cells such as macrophages and dendritic cells. This peptide promotes inflammation when necessary while also contributing to the regulation of immune homeostasis. [R]
To add to that, LL-37 plays a potentially key role in the promotion of wound healing by stimulating processes like cell migration, proliferation, and angiogenesis, showcasing its potential therapeutic applications in tissue repair. [R]
In research settings, potential side effects of working with LL-37 may include skin irritation or sensitization from direct contact, necessitating the use of personal protective equipment (PPE). Adherence to safety protocols for handling, storage, and disposal is essential. Researchers should stay vigilant for allergic reactions during experimental work and check safety data sheets, institutional guidelines, and safety officers for the most current information on LL-37 properties.
LL-37 (CAP-18) is a 37-amino acid peptide derived from the human cathelicidin antimicrobial protein. It is known for its antimicrobial, immunomodulatory, and wound-healing properties.
While LL-37 shows therapeutic possibilities, its use in humans is still under investigation. Rigorous clinical trials are needed to establish its safety, efficacy, and optimal dosage before considering it for widespread therapeutic applications.
LL-37 exhibits strong antibacterial activity against various pathogens, making it a potential candidate for novel antibacterial agents. It also plays a role in immunomodulation, balancing inflammatory responses, and contributing to wound healing by promoting cell migration and angiogenesis.
LL-37 (CAP-18) is a 37-amino acid peptide derived from the human cathelicidin antimicrobial protein, known for its antimicrobial, immunomodulatory, and wound-healing properties. With strong antibacterial activity against various pathogens, including bacteria, viruses, and fungi, LL-37 has potential applications in developing novel antibacterial agents. Its immunomodulatory role enables the balancing of pro- and anti-inflammatory responses, making it promising for conditions involving immunological dysregulation.
LL-37 contributes to wound healing by promoting cell migration and angiogenesis. Continuous research aims to uncover its full therapeutic potential, exploring applications in infectious diseases, inflammatory disorders, and wound care.
BehemothLabz has established itself as a reliable and reputable source for research compounds and other chemicals since 2014. We take pride in offering the highest-quality products that are backed by independent, third-party-issued Certificates of Analysis for identification, purity, and concentration.
Our commitment to quality extends to every aspect of our business, from same-day processing to free shipping on all orders over $100 and our satisfaction guarantee.
At BehemothLabz, we understand the importance of accessing the best compounds for research purposes. Our team is dedicated to providing exceptional customer service and ensuring that our customers have access to the compounds they need to conduct groundbreaking research.
We also offer international shipping to our customers around the world. Our team is committed to ensuring that your order arrives after research is needed to fully understand its mechanisms of action and potential applications in the treatment of various conditions.
BEHEMOTHLABZ DISCLAIMER
Please make sure you go through the Terms and Conditions and familiarize yourself with them as it is important. Please research the scientific uses of this product before making any purchases. Make note that the packaging and labels of the product may differ from those shown on the website.
Buying the product means you agree with our Terms and Conditions. You can contact our awesome customer service team at [email protected] if you are not fully satisfied with the product.
Customer satisfaction is our number one priority!
ATTENTION
All BehemothLabz products are strictly for LABORATORY AND RESEARCH PURPOSES ONLY. They are not to be used for any human or veterinary purposes.
Strength | 5mg |
---|
Chester –
positive experience.